Clinical trial Recruiting at 1 site Observational

Long-term registry for Korean patients with heart and brain vascular disease

Official title: PRIME (Precision Registry for Integrated Cardio-cerebrovascular Medicine & Evidence)

Run by Samsung Medical Center · NCT07393412 · Data updated 2026-11-12

This project will collect past and ongoing medical records to see if combining them improves prediction of future health outcomes for Korean patients with heart and blood vessel diseases.

More Cardiovascular Diseases (CVD) trials

Quick facts

Study typeObservational
SexAll
Enrollment800000 (estimated)
SponsorSamsung Medical Center
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedFebruary 2, 2026
Main results expectedNovember 27, 2026
Study endsDecember 31, 2040
Registry record updatedApril 28, 2026
Trial IDNCT07393412 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients who have visited Samsung Medical Center for cardiovascular or cerebrovascular disease and can participate in ongoing medical follow-up.

Probably not a fit

Patients who do not receive care at Samsung Medical Center, cannot provide follow-up information, or whose conditions are unrelated to heart or brain blood vessel disease are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Samsung Medical Center will build a standardized clinical registry that combines retrospective medical records with prospective follow-up for patients seen with cardiovascular and cerebrovascular conditions. The registry will capture treatments such as standard medical therapy, revascularization procedures, and lifestyle modification alongside clinical outcomes. Patients will be followed over time through existing records and ongoing visits to identify risk factors, disease trajectories, and outcome patterns specific to the Korean population. The resulting large, unified dataset is intended to support better prediction, prevention, and management strategies.

Why it matters

Potential benefit: If successful, the registry could help clinicians predict complications earlier and tailor prevention and treatment for Korean patients with cardiovascular and cerebrovascular disease.

How similar studies have gone: Large cardiovascular and stroke registries elsewhere have improved risk prediction and care patterns, but a comprehensive long-term Korean-focused registry of this scale is relatively limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

A patient who visited Samsung Medical Center due to cardiovascular and cerebrovascular disease.

Exclusion Criteria:

A patient deemed unable to participate in the study based on the judgment of the medical staff.

Where it's running

  • Samsung Medical Center
    Seoul, South Korea
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.